English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52611630    線上人數 :  934
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 481-490 / 1656 (共166頁)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-03-18T02:03:00Z Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy Lin Y.-C.; Wei L.-H.; CHIA-TUNG SHUN; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-18T02:02:53Z Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery Lee J.-M.;Yang S.-Y.;Yang P.-W.;Chia-Tung Shun;Wu M.-T.;Hsu C.-H.;Lin C.-C.;Cheng J.-C.-H.;Wang Y.-H.;Chuang T.-H.;Chen J.-S.;Hsu H.-H.;Huang P.-M.;Kuo S.-W.;Lee Y.-C.; Lee J.-M.; Yang S.-Y.; Yang P.-W.; CHIA-TUNG SHUN; Wu M.-T.; Hsu C.-H.; Lin C.-C.; Cheng J.-C.-H.; Wang Y.-H.; Chuang T.-H.; Chen J.-S.; Hsu H.-H.; Huang P.-M.; Kuo S.-W.; Lee Y.-C.
臺大學術典藏 2021-03-18T02:02:48Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.;Kang Y.K.;Yang T.-S.;Chia-Tung Shun;Shao Y.-Y.;Su W.-C.;Sandoval-Tan J.;Chiou T.-J.;Jin K.;Hsu C.;Cheng A.-L.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-03-18T02:02:23Z Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment Lu L.-C.;Lee Y.-H.;Chang C.-J.;Chia-Tung Shun;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; CHIA-TUNG SHUN; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-15T08:26:16Z AlGaN/GaN high electron mobility transistors for protein-peptide binding affinity study Huang C.-C.; Lee G.-Y.; Chyi J.-I.; HUI-TENG CHENG; Hsu C.-P.; Hsu Y.-R.; Hsu C.-H.; Huang Y.-F.; Sun Y.-C.; Chen C.-C.; Li S.-S.; Andrew Yeh J.; Yao D.-J.; Ren F.; Wang Y.-L.
臺大學術典藏 2021-03-15T07:44:49Z Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer LI-CHUN LU; Shao Y.-Y.; Hsu C.-H.; Hsu C.; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-03-15T07:44:49Z Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy Shao Y.-Y.; LI-CHUN LU; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-15T07:44:49Z Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems Shao Y.-Y.; LI-CHUN LU; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-15T07:44:48Z �]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma LI-CHUN LU; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-15T07:44:48Z Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma LI-CHUN LU; Shao Y.-Y.; Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S.

顯示項目 481-490 / 1656 (共166頁)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
每頁顯示[10|25|50]項目